Annovis Bio
Price & Volume
Stats
See more| 52W Range | $4.79-$22.49 |
| Market Cap | $90.2M |
| Shares Short | 1M |
Financials
See more| Revenue (12 Mos) | $0 |
| Revenue Growth (YoY) | 0% |
| Gross Profit (12 Mos) | $0 |
| Diluted EPS | -$5.14 |
News
See moreYahoo Finance • 7 months ago
Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original Projections
Yahoo Finance • 8 months ago
Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Yahoo Finance • 9 months ago
Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s Study
Yahoo Finance • last year
Annovis Bio Announces the Filing of a Groundbreaking Patent
About
| CEO | Dr. Maria L. Maccecchini Ph.D. |
| Address | 1055 Westlakes Drive, Berwyn, PA, United States, 19312 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Full-Time Employees | 6 |
